Search
Atosiban
go.drugbank.com/drugs/DB09059ApprovedInvestigationalIt is used intravenously to halt premature labor. Although initial studies suggested it could be used as a nasal spray and hence would not require hospital admission, it is not used in that form. … It was first reported in the literature in 1985. Atosiban is licensed in proprietary and generic forms for the delay of imminent pre-term birth in pregnant adult women.
Products: Atosiban EVER Pharma 75 mg/10 ml Konzentrat zur Herstellung einer Infusionslösung, Atosiban Aguettant 6,75 mg/0,9 ml InjektionslösungThiotepa
go.drugbank.com/drugs/DB04572ApprovedInvestigationalIt is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer and bladder cancer. … It is also used as conditioning for Bone marrow transplantation. Its main toxicity is myelosuppression.
Products: TEPADINA 100 mg powder for concentrate for solution for infusion, TEPADINA® 100 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓNRilpivirine
go.drugbank.com/drugs/DB08864ApprovedInvestigational[A31331] Rilpivirine was developed by Tilbotec, Inc. and FDA approved on May 20, 2011. … [A31328] It is a diarylpyrimidine derivative.
Mixtures: ODEFSEY 200 MG/25 MG/25 MG FİLM KAPLI TABLET, 90 ADET, ODEFSEY 200 MG/25 MG/25 MG FİLM KAPLI TABLET, 30 ADETSynonyms: 4-{[4-({4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrileCiprofibrate
go.drugbank.com/drugs/DB09064ApprovedInvestigationalWithdrawnProducts: MODALIM TABLET 100 mg, CIPROFIBRATO 100 MG TABLETASFingolimod
go.drugbank.com/drugs/DB08868ApprovedInvestigationalIt was developed by Novartis and initially approved by the FDA in 2010.[L12651] Fingolimod was also studied for the treatment of COVID-19, the disease caused by infection with the SARS-CoV-2 virus. … Multiple sclerosis, or MS, is a devastating inflammatory disease that often progresses and causes severe neurological, physical, and cognitive effects.
Products: FINGOLIMOD EG, GILENYA (0.5 MG)Nicergoline
go.drugbank.com/drugs/DB00699ApprovedIt has been suggested to ameliorate cognitive deficits in cerebrovascular disease.
Synonyms: 10-methoxy-1,6-dimethylergoline-8β-methanol 5-bromonicotinate, (8β)-10-methoxy-1,6-dimethylergoline-8-methanol 5-bromo-3-pyridinecarboxylate (ester)Products: SERMION (10 MG), NICERGOLIN-NEURAX 10 MGLevosimendan
go.drugbank.com/drugs/DB00922ApprovedInvestigationalWithdrawnIt also relaxes vascular smooth muscle by opening adenosine triphosphate sensitive potassium channels. Levosimendan is used to manage acutely decompensated congestive heart failure.
Products: LEVOSIMENDAN EG, DAXIM® 2.5 MG / MLGlimepiride
go.drugbank.com/drugs/DB00222ApprovedInvestigational[A177703] It is effective in reducing fasting plasma glucose, postprandial glucose, and glycosylated hemoglobin levels and is considered to be a useful, cost-effective treatment option for managing type … It is sometimes classified as a third-generation SU because it has larger substitutions than other second-generation SUs.
Mixtures: AMARYL®M 1 MG/ 500 MG, AMARYL M SR (TABLET 2/500 MG)Products: AMARYL 1.0 TABLETS 1 mg, AMARYL 2.0 TABLETS 2 mgDexrazoxane
go.drugbank.com/drugs/DB00380ApprovedInvestigationalWithdrawnIt appears to inhibit formation of a toxic iron-anthracycline complex.
Products: Cyrdanax 20 mg/ml Pulver zur Herstellung einer InfusionslösungPalbociclib
go.drugbank.com/drugs/DB09073ApprovedInvestigationalIt is a second generation cyclin-dependent kinase inhibitor[A176798] selected from a group of pyridopyrimidine compounds due to its favorable physical and pharmaceutical properties. … [L5867] It was originally FDA approved on March 2015 for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer and its indications were updated in April 2019 to include male
Products: REAMPLA 100 MG KAPSÜL, 7 KAPSÜL, REAMPLA 100 MG KAPSÜL, 21 KAPSÜL